What is AQST stock price today?

Visit our real-time dashboard for the current AQST stock price and live market data.

Is AQST stock going up or down today?

AQST stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy AQST stock now?

The decision to buy AQST depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is AQST a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for AQST based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is AQST stock overvalued or undervalued?

Use our DCF valuation calculator to determine if AQST is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is AQST's P/E ratio?

P/E ratio data for AQST will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is AQST's market cap?

AQST (Aquestive Therapeutics Inc) has a market capitalization of $0.49 billion, making it a small-cap stock.

What is AQST's price to book ratio?

Price-to-book ratio for AQST is available on our dashboard along with other valuation metrics.

Does AQST pay dividends?

AQST does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is AQST's dividend yield?

AQST does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is AQST stock a good long-term investment?

AQST's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is AQST's revenue growth rate?

Revenue growth data for AQST is available on our dashboard with detailed financial statement analysis.

Profitability metrics for AQST are available on our dashboard with complete income statement analysis.

What are the risks of investing in AQST?

Key risks for AQST include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does AQST compare to its competitors?

Compare AQST to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize AQST's performance and positioning.

What is AQST's stock price target for 2026?

Visit our prediction page for AI-powered price targets for AQST with bull, base, and bear case scenarios.

What do analysts say about AQST?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for AQST. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is AQST's next earnings report?

AQST reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

AQST - Aquestive Therapeutics Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Aquestive Therapeutics Inc

Aquestive Therapeutics Inc (AQST) common stock

Price Chart

Loading chart...

AQST Key Statistics

Market Cap

$493.02M

How AQST Compares to Peers

AQST is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 2

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 3

Company	Market Cap	P/E	Growth	Margin	Compare
AQST(This stock)	$493.02M	N/A	0%	0.0%	-
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: June 15, 2026 at 4:52 AM EDT

Ready to invest in AQST?

Commission-free trading available. Affiliate links.

AQST Lician Score

10% confidence

5.0/10

Neutral

AQST has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates AQSTacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

AQST Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for AQST

Dashboard

Enter a ticker to analyze